Skip to main content
letter
. 2019 Dec 26;14:298. doi: 10.1186/s13023-019-1278-z

Table 2.

Safety outcomes

Major bleedings (n/total) 0/12
CRNM bleedings (n/total) 0/12
Minor bleedings different from epistaxis (n/total) 0/12
Worsening of Epistaxis (n/total) 1/12
ESS at enrolment vs during AT (mean ± SD) 3.9 ± 2.8 vs 3.2 ± 2.6 (95% IC −3.2-1.5, p = 0.2988)
Mean Hb at enrolment vs during AT (g/dl ± SD) 11.4 ± 2.9 vs 11.5 ± 2.5 (95% CI −1.5-1.5, p = 0.9609)
Patients needing transfusions prior to AT vs during AT (n/total) 1/12 vs 0/12
Discontinuation of AT (n/total) 0/12